Table 5.
Study | Year | Paclitaxel delivery method | Dose |
Cmax_IP
(μmol/L)a |
T
max_IP
(hours) |
Cmax_IP/ |
AUCIP/ |
---|---|---|---|---|---|---|---|
Markman [33] | 1992 | Instillation IP chemotherapy | 25–175 mg/m2/3–4 weeks | 175b | 0.5–1 | ~1000 | 996d |
Francis [31] | 1995 | Instillation IP chemotherapy | 30–75 mg/m2/week | 50–1273c | 0.5–2 | ||
Hofstra [34] | 2002 | Instillation IP chemotherapy | 75 mg/m2 D1 + 8/4 week | 1350d | |||
Mohamed [35] | 2003 | Instillation IP chemotherapy | 20 mg/m2/day for 5 days | ~45 | 0.25 | ~800 | |
deBree [12] | 2008 | HIPEC | 175 mg/m2 for 2 h | 118 | 0.08 | 1178 | 1462 for 2 h (366 total for 5 days period) |
Nanotax® | 2014 | Instillation IP chemotherapy | 50–275 mg/m2/4 weeks | 1–61c | 56 | 1168 |
Mean values
Mean value for 50–175 mg/m2 range
Range, not mean value
For the duration of IP instillation chemotherapy